| 得舒特、双歧杆菌四联活菌联合黛力新治疗肠易激综合征 |
| |
| 引用本文： | 张振辉. 得舒特、双歧杆菌四联活菌联合黛力新治疗肠易激综合征[J]. 医疗保健器具, 2011, 18(4): 558-559. DOI: 10.3936/j.issn.1674-4659.2011.04.0558 |
| |
| 作者姓名： | 张振辉 |
| |
| 作者单位： | 广东省东莞市中堂医院内科,广东,东莞,523220 |
| |
| 摘 要： | 目的探讨得舒特、双歧杆菌四联活菌和黛力新联合使用治疗肠易激综合征（IBS）的临床疗效。方法于我院选择269例IBS患者随机分成A、B、C三个组,A组98例口服得舒特50 mg,3次/d,双歧杆菌四联活菌1.5 g,3次/d,黛力新1片,1次/d;B组85例给予口服得舒特50 mg,3次/d,双歧杆菌四联活菌1.5 g,3次/d;C组86例口服得舒特50 mg,3次/d,黛力新1片,1次/d。三组治疗均于4周后比较疗效,观察服药前后IBS的症状、大便性状情况及抑郁状态,并进行量化评分比较。结果 A、B、C三种疗法治疗肠易激综合征有效率比较差异有统计学意义（P〈0.05）,通过各组疗法间的两两比较,A与B、A与C组之间比较差异有统计学意义（P〈0.05）,而B组与C组之间比较差异无统计学意义（P〉0.05）。结论得舒特、双歧杆菌四联活菌、黛力新合用治疗IBS比得舒特联合双歧杆菌四联活菌及得舒特联合黛力新的效果要好。
|
| 关 键 词： | 肠易激综合征 得舒特 双歧杆菌四联活菌 黛力新 |
Combination Treatment with Pinaverium Bromide,Quadruple Viable Bifidobacterium and Deanxit on Irritable Bowel Syndrome(IBS) |
| |
| ZHANG Zhenhui. Combination Treatment with Pinaverium Bromide,Quadruple Viable Bifidobacterium and Deanxit on Irritable Bowel Syndrome(IBS)[J]. Medicine Healthcare Apparatus, 2011, 18(4): 558-559. DOI: 10.3936/j.issn.1674-4659.2011.04.0558 |
| |
| Authors: | ZHANG Zhenhui |
| |
| Affiliation: | ZHANG Zhenhui(Department of Internal Medicine,Zhongtang Hospital,Dongguan 523220,China) |
| |
| Abstract: | Objective To investigate the clinical effect of combination treatment with pinaverium bromide,quadruple viable bifidobacterium and deanxit on irritable bowel syndrome(IBS).Methods 269 patients with irritable bowel syndrome in our hospital selected were randomly divided into three groups,they were A group,B group and C group.A group of 98 patients with oral administration of 50 mg pinaverium bromide 3 times a day,1.5 g bifidobacterium viable 3 times a day,1 pill of deanxit 1 times a day;B group of 85 patient... |
| |
| Keywords: | Irritable bowel syndrome Pinaverium bromide Quadruple viable bifidobacterium Deanxit |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
